Madhura A. Tamhankar, MD

Ophthalmology
Accepting new patients
Sees patients age 18 and up
Scheie Eye Institute Penn Presbyterian
Make an appointmentCall 215-662-8100
Headshot of Madhura A. Tamhankar, MD
Penn Medicine Provider

About me

  • Professor of Ophthalmology at the Hospital of the University of Pennsylvania
  • Professor of Neurology

Dr. Tamhankar is a Professor of Ophthalmology at the Scheie Eye Institute, University of Pennsylvania. She is fellowship trained in Neuro-ophthalmology and serves as the primary point of contact for referrals from various specialties, including neurosurgery, neurology, endocrinology, rheumatology, and general medicine. She is also the only adult strabismus surgeon at the institute, with a large referral network for strabismus surgery, attracting patients from Philadelphia and its surrounding suburbs. Additionally, she co-leads the thyroid eye disease clinic in collaboration with the oculoplastic service. This clinic is a key referral center for patients seeking medical and surgical treatments for complex thyroid eye disease and those considering participation in clinical trials.

Dr. Tamhankar has research interests in thyroid eye disease and giant cell arteritis.

She is the principal investigator on several industry-sponsored clinical trials exploring new therapies for thyroid eye disease. She collaborates with an international Vasculitis Clinical Research Consortium to study MR imaging in giant cell arteritis and helped develop a standardized imaging protocol and scoring system.

My education and training

  • Medical School: Lokmanya Tilak Municipal Medical College
  • Residency: St. Mary's Hospital - Waterbury, CT
  • Residency: University of Pennsylvania Health System
  • Fellowship: University of Pennsylvania Health System

Spoken languages

English
English
मराठी
Marathi
हिन्दी
Hindi

Reviews

Average Rating

1388 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
May 2026
i am very grateful to have dr. tamhankar doing my surgery.
Anonymous
May 2026
excellent doctor
Anonymous
May 2026
dr. t is amazing!
Anonymous
May 2026
she takes the time to listen to my concerns and answers all of my questions.

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Tamhankar is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

Research

Publications

Ahmed W, Gandhi OH, Yu N, Brant J, Hwa T, Bagley L, Tamhankar M, Feroze A, Choudhri O. Efficacy of glucagon-like peptide-1 receptor agonists in idiopathic intracranial hypertension: A systematic review and meta-analysis. , J. Neurol Sci. , 480: 2026,125711

Levin LA, Bhatti MT, Klier S, Morgenstern R, Szanto D, Miller NR, Kupersmith MJ; Quark NAION Study Group. A Randomized Sham-Controlled Phase 2/3 Trial of QPI-1007 for Acute Nonarteritic Anterior Ischemic Optic Neuropathy. , Ophthalmology, 133(1): 2026,62-74

Shah SA, Chandraparnik P, Choi S, Amarikwa L, Guniganti R, Walsh HL, Rubio RH, Linaburg T, Meyer E, Reem K, Sears C, Goldin M, Kinde B, Dosiou C, Malik A, Mawn L, Shinder R, Wester S, Rootman D, Cockerham K, Tamhankar M, Couch S, Harrison A, Kossler AL. The Efficacy and Safety of Teprotumumab in Geriatrics Patients: A Multicenter Study. , OPRS , 42(1): 2026,102-109

Yuanyuan Chen, Taylor Linaburg, Sarah Wang, Gibran Merchant, Tejus Pradeep, Patrick Anthony Augello, Gui-shuang Ying, César A. Briceño, Madhura A. Tamhankar Observational Characterization of the Re-treatment Course of Patients with Thyroid Eye Disease , Journal of Neuro-ophthalmology: 2025

Tamhankar MA, Raza S, Brutsaert E, Urdániz E, Vainilovich Y, Heyes A, Gildea L, Sales-Sanz M. The burden of illness in thyroid eye disease: current state of the evidence. , Front Ophthalmol(Lausanne)., 5: 2025

Rennie L. Rhee, Girish Bathla, Ryan Rebello, Robert M. Kurtz, Mats Junek, Kenneth J. Warrington, Nader Khalidi, Peter A. Merkel1, Konstanze V. Guggenberger, Madhura A. Tamhankar, Thorsten A. Bley for the Vasculitis Clinical Research Consortium Vessel wall MRI in giant cell arteritis: standardized protocol and scoring approach developed by an international working group , Rheumatology, 64(5): 2025,2910-2918

Linaburg TJ, Pradeep T, Rinelli B, Chen Y, Chen Y, Ying GS, Briceño CA, Tamhankar M Comparison of ophthalmic surgery rates in teprotumumab-treated vs. teprotumumab-untreated thyroid eye disease patients. , Arq Bras Oftalmol, 88(5): 2025,2024-0319

Kasi S, Volpe NJ, Pistilli M, Tamhankar MA Effectiveness of Medial Rectus Advancement Alone or in Combination with Resection or Lateral Rectus Recession in the Management of Consecutive Exotropia. , JAAPOS, 17(5): 2013,465-470

Madhura Tamhankar, Brady kwong Maxwell Pistilli Benefits and side effects of prisms in the management of diplopia in adults: a prospective study , Journal of the American Association for Pediatric Ophthalmology and Strabismus. , 25(2): 2021,85.e1-85.e6

Kruszewski AM, Tamhankar MA. Ophthalmic Manifestations of Giant Cell Arteritis , Int Ophthalmol Clin, 63(2): 2023,13-23

View all publications